Oncology Biosimilar Market Size is projected to reach USD 15.62 billion by 2031, growing at a CAGR of 20.5%: Straits Research New York, United States, Nov. 23, 2022 (GLOBE NEWSWIRE) -- A biosimilar is a generic version of a well-known biologic drug. Biologic drugs are medicines made from living things like cells, tissues,...

Oncology Biosimilar Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis Pune, India, March 15, 2022 (GLOBE NEWSWIRE) -- The global oncology biosimilar market is poised for rapid growth as patents of expensive biologic drugs are on the verge of expiration. Key insights...

US Cancer Biosimilar Market Size Sales Opportunity Oncology Biosimilars Clinical Trials Outlook 2026 DELHI, India, March 08, 2021 (GLOBE NEWSWIRE) -- "US Cancer Biosimilar Market Opportunity, Drug Dosage, Price & Clinical Trials Insight 2026" Report highlights: US Cancer Biosimilar Market...

Global Oncology Biosimilar Market Will Reach USD 13,993.64 Million by 2024: Zion Market Research New York, NY, July 24, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Oncology Biosimilar Market by Cancer Type (Breast Cancer, Colorectal Cancer, Blood Cancer,...